Unicon Optical Co., Ltd. (TPEX:4150)
Taiwan · Delayed Price · Currency is TWD 10.45
+0.30 (2.96%)
Jul 16, 2025, 2:54 PM CST
Unicon Optical Revenue
In the year 2024, Unicon Optical had annual revenue of 909.45M TWD with 7.54% growth. Unicon Optical had revenue of 452.63M in the half year ending December 31, 2024, with 10.86% growth.
Revenue
909.45M
Revenue Growth
+7.54%
P/S Ratio
1.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 909.45M | 63.78M | 7.54% |
| Dec 31, 2023 | 845.67M | 20.23M | 2.45% |
| Dec 31, 2022 | 825.44M | -72.64M | -8.09% |
| Dec 31, 2021 | 898.08M | -215.58M | -19.36% |
| Dec 31, 2020 | 1.11B | -122.62M | -9.92% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Oneness Biotech | 117.33M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |